CHPF2 anticorps (N-Term)

N° du produit ABIN6258759

Détail du produit anti-CHPF2 anticorps

Antigène: CHPF2 (Chondroitin Polymerizing Factor 2 (CHPF2))

Épitope: N-Term

Reactivité: Humain

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp CHPF2 est non-conjugé

Application: Western Blotting (WB), ELISA, Immunocytochemistry (ICC), Immunofluorescence (IF)

Specificité: CSGLCAT Antibody detects endogenous levels of total CSGLCAT.

Homologie: Pig,Bovine,Horse,Sheep,Dog

Purification: The antiserum was purified by peptide affinity chromatography using SulfoLink^TM Coupling Resin (Thermo Fisher Scientific).

Immunogène: A synthesized peptide derived from human CSGLCAT, corresponding to a region within N-terminal amino acids.

Isotype: IgG

Information d'application

Indications d'application: WB 1:500-1:1000, IF/ICC 1:100-1:500, ELISA(peptide) 1:20000-1:40000

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: 1 mg/mL

Buffer: Rabbit IgG in phosphate buffered saline , pH 7.4, 150 mM NaCl, 0.02 % sodium azide and 50 % glycerol.

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: -20 °C

Stockage commentaire: Store at -20 °C. Stable for 12 months from date of receipt.

Date de péremption: 12 months

Détails sur CHPF2

Antigène: CHPF2 (Chondroitin Polymerizing Factor 2 (CHPF2))

Autre désignation: CHPF2 (CHPF2 Produits)

Synonymes: anticorps RGD1306404, anticorps AW060945, anticorps mKIAA1402, anticorps 2010209O12Rik, anticorps CSGLCA-T, anticorps CSGlcAT, anticorps ChSy-3, anticorps chondroitin polymerizing factor 2, anticorps Chpf2, anticorps CHPF2, anticorps chpf2

Sujet:

Description: Transfers glucuronic acid (GlcUA) from UDP-GlcUA to N-acetylgalactosamine residues on the non-reducing end of the elongating chondroitin polymer. Has no N-acetylgalactosaminyltransferase activity.

Gene: CHPF2

Poids moléculaire: 86 kDa

ID gène: 54480

UniProt: Q9P2E5

Pathways: Glycosaminoglycan Metabolic Process